Sonnet Biotherapeutics (SONN) has had the highest return since July 1, 2025 by a nano-cap US stock, returning 694.3%.
Sonnet Biotherapeutics (SONN) has had the highest return since July 1, 2025 by a nano-cap US stock, returning 694.3%.
| ASSET | % RETURN |
|---|---|
| Sonnet Biotherapeutics (SONN) | 694.31% |
| Lixte Biotechnology (LIXTW) | 480.65% |
| Lixte Biotechnology (LIXT) | 260.19% |
| Trident Digital Tech Holdings Ltd American Depository Shares (TDTH) | 190% |
| Mustang Bio (MBIO) | 151.58% |
| Innovation Beverage (IBG) | 147.37% |
| Cyclacel Pharmaceuticals (CYCC) | 145.37% |
| Signing Day Sports (SGN) | 135.92% |
| SU Group Holdings Limited Ordinary Shares (SUGP) | 129.79% |
| Future Fintech (FTFT) | 127.83% |
| ENDRA Life Sciences (NDRA) | 126.69% |
| Bit Origin (BTOG) | 114.81% |
| BP Prudhoe Bay Royalty Trust (BPT) | 112.5% |
| Moleculin Biotech (MBRX) | 111.68% |
| Stardust Power (SDST) | 108.04% |
| Evoke Pharma (EVOK) | 97.31% |
| Workhorse (WKHS) | 97.22% |
| Optical Cable (OCC) | 94.35% |
| Global Interactive Technologies (GITS) | 87.5% |
| Oxbridge Re Holdings Equity Warrant (OXBRW) | 81.93% |
| Cognition Therapeutics (CGTX) | 81.47% |
| Cambium Networks (CMBM) | 81.42% |
| Carbon Revolution Public Limited Ordinary Shares (CREV) | 80.21% |
| Offerpad Solutions (OPAD) | 80% |
| Nova Lifestyle I (NVFY) | 79.26% |
Nano-cap stocks are treated as having a market cap of <= $50M.